We use cookies for a better user experience. Read our Privacy Policy

I Agree

Industry Verticals »

All Categories

Insights »

About TMR »

Immunoglobulins Market

Schedule a Call

Immunoglobulins Market

Immunoglobulins Market (Applications - Neurology, Immunology, Hematology; Route of Administration - Intravenous, Subcutaneous, Intramuscular; End user - Hospital, Clinic, Homecare) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Global Immunoglobulins Market - Snapshot

The global immunoglobulins market is expected to reach a market value of about US$ 20,757 Mn by the end of 2026, expanding at a high single digit CAGR during the forecast period. Rise in prevalence of diseases related to neurology, immunology, hematology, and other deficiencies, rising geriatric population across the globe, leading to diseases, adoption, and awareness of effective immunoglobulins products, improving healthcare infrastructure, and rich product pipeline are expected to boost the global immunoglobulins market during the forecast period. Surge in investments by key players through collaborations, mergers, and acquisition are expected to propel the global immunoglobulins market during the forecast period. However, the high cost of treatments and severe side-effects associated with infusions are expected to hamper the immunoglobulins market. Niche rare disease segment with limited product availability is likely to fuel the market. 

immunoglobulins market

The global immunoglobulins market has been segmented based on applications, route of administration, and end-user. In terms of applications, the global market has been classified into neurology, immunology, hematology, and others. The neurology segment dominates the global immunoglobulins market, in terms of value, owing to its indication prevalence. This immunology segment is expected to expand at a significant CAGR owing to higher prevalence of idiopathic thrombocytopenic purpura (ITP), primary immunodeficiency, and other indications. Based on route of administration, the global immunoglobulins market has been divided into intravenous, subcutaneous, and intramuscular. The intravenous segment held a major share of the market in 2017. It is expected to maintain its leading position, in terms of market share, during the forecast period owing to its rapid onset of action. However, benefits of subcutaneous over intravenous are presently slowly adaptable in the market and hence, the subcutaneous segment is projected to expand at a notable CAGR during the forecast period. 

In terms of end-user, the global immunoglobulins market has been segregated into hospital, clinic, and homecare. The hospital segment held a major share of the market in 2017, followed by clinic and homecare segments, owing to the acceptance of advanced treatment requiring hospitalization. The homecare segment is projected to expand at a considerable CAGR during the forecast period owing to easy administration of infusions at home, supporting personal care, as well as it saves the cost of treatment. In developing countries, the medical care isn’t funded completely by the government; hence, the rising adoption of homecare is advantageous to patients. Preference of subcutaneous products is also driving the homecare segment 

In terms of geography, the global immunoglobulins market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global immunoglobulins market owing to major acceptance of intravenous infusions, increasing plasma yield, healthcare investments by the government, and presence of major players in the region. According to the Immune Deficiency Foundation (IDF), there are more than 5 million undiagnosed cases in the U.S., which in turn is driving innovative therapeutic treatments and huge investments. Rising incidence of neurological, autoimmune disorders is boosting the demand for effective treatment, which in turn is a major factor driving the market in North America. The market in Asia Pacific is projected to expand at a significantly high CAGR during the forecast period, owing to improving health care infrastructure, rising investments in research and development, increasing disposable income, awareness about IVIG infusions in countries, such as China and India, and increasing acceptance of SCIG infusions in the region. IVIG accounts for a prominent share of the plasma market in China. Furthermore, the prevalence of CIDP, ITP diseases is anticipated to further boost the market in Asia Pacific in the near future. 

Major players operating in the global immunoglobulins market include Shire, CSL Behring, Kedrion Biopharma Inc, Grifols, S.A., Octapharma, China Biologic Products Holdings Inc, Biotest AG, Sanquin, and LFB SA. Key players are focusing on geographic expansion through acquisitions and collaborations to enhance their footprint in the global immunoglobulins market. Furthermore, companies are investing in pipeline products for building strong product portfolio.

IVIg Usage in Treating Severe COVID-19 Cases will bring Good Growth Opportunities for the Immunoglobulins Market

The immunoglobulins market is extrapolated to gain intensive growth opportunities owing to the increasing cases of immunodeficiency. The changing lifestyle habits and hectic work schedules have led to problems related to immunodeficiency. Thus, this aspect will bring good growth opportunities for the immunoglobulins market during the forecast period of 2018-2026.

  • Immunoglobulins are glycoproteins created in response to an immunogen by plasma cells and act as antibodies. They generally bind to antigenic determinants and eliminate the threat of infections. Hence, all these aspects bring exponential growth for the immunoglobulins market.
  • The booming geriatric population and a rise in the number of hemophilic patients will serve as a vital growth generator for the immunoglobulins market. The popularity of immunoglobulin therapy as the preferred treatment for immunodeficiency and other rare neurological diseases may invite exponential growth for the immunoglobulins market. The escalating focus on immune disorder diagnosis will serve as a prominent growth factor. Quick regulatory approvals are also helping in boosting the growth prospects of the immunoglobulins market.
  • Research and development activities are playing a crucial role in the growth of the immunoglobulins market. The players in the immunoglobulins market focus on these activities for discovering unique insights. The insights assist in boosting the revenues of the players in the immunoglobulins market, ultimately adding extra stars of growth.
  • The COVID-19 outbreak is one of the worst pandemics the world has ever faced. The rapid transmission rate and the high fatality rate have left many scientists and researchers searching for a good treatment option. Many options have been discovered by researchers and scientists. The utilization of immunoglobulins is one of them. The utilization of Intravenous immunoglobulin (IVIg) for treating serious COVID-19 patients is being considered by many scientists and researchers. A recent study also showcased the efficacy of IVIg in treating COVID-19 patients. Thus, this aspect can bring great growth opportunities for the immunoglobulins market.

The global immunoglobulins market has been segmented as below:

by Applications
  • Neurology
  • Immunology
  • Hematology
  • Others

by Route Of Administration
  • Intravenous
  • Subcutaneous
  • Intramuscular

by End-user
  • Hospital
  • Clinic
  • Homecare

by Region
  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • GCC Countries
    • Rest of Middle East & Africa

    1. Preface
         1.1. Market Definition and Scope
         1.2. Market Segmentation
         1.3. Key Research Objectives
         1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary : Global Immunoglobulins Market

    4. Market Overview
         4.1. Introduction
                4.1.1. Market Definition
                4.1.2. Industry Evolution / Developments
         4.2. Overview
         4.3. Market Dynamics
                4.3.1. Drivers
                4.3.2. Restraints
                4.3.3. Opportunities
         4.4. Global Immunoglobulins Market Analysis and Forecast, 2016–2026
                4.4.1. Global Immunoglobulins Market Value (US$ Mn) Projections
         4.5. Porter’s Five Force Analysis

    5. Market Outlook
         5.1. Disease Prevalence & Incidence Rate Globally with Key Countries
         5.2. Regulatory Scenario by Region/globally
         5.3. Pipeline Analysis

    6. Global Immunoglobulins Market Analysis and Forecast, by Applications 
         6.1. Introduction & Definition
         6.2. Key Findings / Developments
         6.3. Global Immunoglobulins Market Value Forecast, by Applications, 2016–2026
                6.3.1. Neurology
                6.3.2. Immunology
                6.3.3. Hematology
                6.3.4. Others
         6.4. Global Immunoglobulins Market Attractiveness by Applications 

    7. Global Immunoglobulins Market Analysis and Forecast, by Route of Administration 
         7.1. Introduction & Definition
         7.2. Key Findings / Developments
         7.3. Global Immunoglobulins Market Value Forecast, by Route of Administration, 2016–2026
                7.3.1. Intravenous
                7.3.2. Subcutaneous
                7.3.3. Intramuscular     
         7.4. Global Immunoglobulins Market Attractiveness by Route of Administration 

    8. Global Immunoglobulins Market Analysis and Forecast, by End-user 
         8.1. Introduction & Definition
         8.2. Key Findings / Developments
         8.3. Global Immunoglobulins Market Value Forecast, by End-user, 2016–2026
                8.3.1. Hospital
                8.3.2. Clinic
                8.3.3. Homecare
         8.4. Global Immunoglobulins Market Attractiveness by End-user 

    9. Global Immunoglobulins Market Analysis and Forecast, by Region
         9.1. Key Findings
         9.2. Global Immunoglobulins Market Value Forecast, by Region
                9.2.1. North America 
                9.2.2. Europe 
                9.2.3. Asia Pacific 
                9.2.4. Latin America 
                9.2.5. Middle East & Africa      
         9.3. Global Immunoglobulins Market Attractiveness, by Country/Region

    10. North America Immunoglobulins Market Analysis and Forecast
         10.1. Introduction
                10.1.1. Key Findings
         10.2. North America Immunoglobulins Market Value Forecast, by Applications, 2016–2026
                10.2.1. Neurology
                10.2.2. Immunology
                10.2.3. Hematology
                10.2.4. Others
         10.3. North America Immunoglobulins Market Value Forecast, by Route of Administration, 2016–2026
                10.3.1. Intravenous
                10.3.2. Subcutaneous
                10.3.3. Intramuscular
         10.4. North America Immunoglobulins Market Value Forecast, by End-user, 2016–2026
                10.4.1. Hospital
                10.4.2. Clinic
                10.4.3. Homecare
         10.5 North America Immunoglobulins Market Value Forecast, by Country, 2016–2026
                10.5.1. US
                10.5.2. Canada 
         10.6. North America Immunoglobulins Market Attractiveness Analysis 
                10.6.1. By Applications 
                10.6.2. By Route of Administration 
                10.6.3. By End-user 
                10.6.4. By Country

    11. Europe Immunoglobulins Market Analysis and Forecast
         11.1. Introduction
                11.1.1. Key Findings
         11.2. Europe Immunoglobulins Market Value Forecast by Applications, 2016–2026
                11.2.1. Neurology
                11.2.2. Immunology
                11.2.3. Hematology
                11.2.4. Others
         11.3. Europe Immunoglobulins Market Value Forecast, by Route of Administration, 2016–2026
                11.3.1. Intravenous
                11.3.2. Subcutaneous
                11.3.3. Intramuscular
         11.4. Europe Immunoglobulins Market Value Forecast, by End-user, 2016–2026
                11.4.1. Hospital
                11.4.2. Clinic
                11.4.3. Homecare
         11.5. Europe Immunoglobulins Market Value Forecast, by Country/Sub-region, 2016–2026
                11.5.1. Germany
                11.5.2. France
                11.5.3. U.K.
                11.5.4. Italy
                11.5.5. Spain
                11.5.6. Rest of Europe
         11.6. Europe Immunoglobulins Market Attractiveness Analysis 
                11.6.1. By Applications 
                11.6.2. By Route of Administration 
                11.6.3. By End-user 
                11.6.4. By Country/Sub-region

    12. Asia Pacific Immunoglobulins Market Analysis and Forecast
         12.1. Introduction
                12.1.1. Key Findings
         12.2. Asia Pacific Immunoglobulins Market Value Forecast, by Applications, 2016–2026
                12.2.1. Neurology
                12.2.2. Immunology
                12.2.3. Hematology
                12.2.4. Others
         12.3. Asia Pacific Immunoglobulins Market Value Forecast, by Route of Administration, 2016–2026
                12.3.1. Intravenous
                12.3.2. Subcutaneous
                12.3.3. Intramuscular
         12.4. Asia Pacific Immunoglobulins Market Value Forecast, by End-user, 2016–2026
                12.4.1. Hospital
                12.4.2. Clinic
                12.4.3. Homecare
         12.5. Asia Pacific Immunoglobulins Market Value Forecast, by Country/Sub-region, 2016–2026
                12.5.1. Japan
                12.5.2. China
                12.5.3. India
                12.5.4. Australia & New Zealand
                12.5.5. Rest of Asia Pacific
         12.6. Asia Pacific Immunoglobulins Market Attractiveness Analysis 
                12.6.1. By Applications 
                12.6.2. By Route of Administration 
                12.6.3. By End-user 
                12.6.4. By Country/Sub-region

    13. Latin America Immunoglobulins Market Analysis and Forecast
         13.1. Introduction
                13.1.1. Key Findings
         13.2. Latin America Immunoglobulins Market Value Forecast, by Applications, 2016–2026
                13.2.1. Neurology
                13.2.2. Immunology
                13.2.3. Hematology
                13.2.4. Others
         13.3. Latin America Immunoglobulins Market Value Forecast, by Route of Administration, 2016–2026
                13.3.1. Intravenous
                13.3.2. Subcutaneous
                13.3.3. Intramuscular
         13.4. Latin America Immunoglobulins Market Value Forecast, by End-user, 2016–2026
                13.4.1. Hospital
                13.4.2. Clinic
                13.4.3. Homecare
         13.5. Latin America Immunoglobulins Market Value Forecast, by Country/Sub-region, 2016–2026
                13.5.1. Brazil
                13.5.2. Mexico
                13.5.3. Rest of Latin America
         13.6. Latin America Immunoglobulins Market Attractiveness Analysis 
                13.6.1. By Applications 
                13.6.2. By Route of Administration 
                13.6.3. By End-user 
                13.6.4. By Country/Sub-region

    14. Middle East & Africa Immunoglobulins Market Analysis and Forecast
         14.1. Introduction
                14.1.1. Key Findings
         14.2. Latin America Immunoglobulins Market Value Forecast, by Applications, 2016–2026
                14.2.1. Neurology
                14.2.2. Immunology
                14.2.3. Hematology
                14.2.4. Others
         14.3. Latin America Immunoglobulins Market Value Forecast, by Route of Administration, 2016–2026
                14.3.1. Intravenous
                14.3.2. Subcutaneous
                14.3.3. Intramuscular
         14.4. Latin America Immunoglobulins Market Value Forecast, by End-user, 2016–2026
                14.4.1. Hospital
                14.4.2. Clinic
                14.4.3. Homecare
         14.5. Latin America Immunoglobulins Market Value Forecast, by Country/Sub-region, 2016–2026
                14.5.1. GCC Countries
                14.5.2. South Africa
                14.5.3. Rest of Middle East & Africa
         14.6. Latin America Immunoglobulins Market Attractiveness Analysis 
                14.6.1. By Applications 
                14.6.2. By Route of Administration 
                14.6.3. By End-user 
                14.6.4. By Country/Sub-region
                
    15. Competition Landscape
         15.1. Market Player – Competition Matrix (by Tier and Size of companies)
         15.2. Market Share Analysis by Company (2016)
         15.3. Company Profiles
                15.3.1. Shire
                15.3.2. CSL Behring 
                15.3.3. Kedrion Biopharma Inc 
                15.3.4. Grifols, S.A.
                15.3.5. Octapharma
                15.3.6. China Biologic Products Holdings, Inc
                15.3.7. Biotest AG
                15.3.8. Sanquin
                15.3.9. LFB SA

    List of Tables

    Table 01: Global Immunoglobulins Market Value (US$ Mn) Forecast, by Applications, 2016–2026
    Table 02: Global Immunoglobulins Market Value (US$ Mn) Forecast, by Route of Administration, 2016–2026
    Table 03: Global Immunoglobulins Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 04: Global Immunoglobulins Market Value (US$ Mn) Forecast, by Region, 2016–2026
    Table 05: North America Immunoglobulins Value (US$ Mn) Forecast, by Applications, 2016–2026
    Table 06: North America Immunoglobulins Value (US$ Mn) Forecast, by Route of Administration, 2016–2026
    Table 07: North America Immunoglobulins Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 08: North America Immunoglobulins Market Value (US$ Mn) Forecast, by Country, 2016–2026
    Table 09: Europe Immunoglobulins Value (US$ Mn) Forecast, by Applications, 2016–2026
    Table 10: Europe Immunoglobulins Value (US$ Mn) Forecast, by Route of Administration, 2016–2026
    Table 11: Europe Immunoglobulins Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 12: Europe Immunoglobulins Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
    Table 13: Asia Pacific Immunoglobulins Value (US$ Mn) Forecast, by Applications, 2016–2026
    Table 14: Asia Pacific Immunoglobulins Value (US$ Mn) Forecast, by Route of Administration, 2016–2026
    Table 15: Asia Pacific Immunoglobulins Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 16: Asia Pacific Immunoglobulins Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
    Table 17: Latin America Immunoglobulins Value (US$ Mn) Forecast, by Applications, 2016–2026
    Table 18: Latin America Immunoglobulins Value (US$ Mn) Forecast, by Route of Administration, 2016–2026
    Table 19: Latin America Immunoglobulins Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 20: Latin America Immunoglobulins Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
    Table 21: Middle East & Africa Immunoglobulins Value (US$ Mn) Forecast, by Applications, 2016–2026
    Table 22: Middle East & Africa Immunoglobulins Value (US$ Mn) Forecast, by Route of Administration, 2016–2026
    Table 23: Middle East & Africa Immunoglobulins Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 24: Middle East & Africa Immunoglobulins Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026

    List of Figures

    Figure 01: Global Immunoglobulins Market Snapshot
    Figure 02: Global Immunoglobulins Market Value (US$ Mn) and Distribution, by Region, 2017 and 2026
    Figure 03: Global Immunoglobulins Market Snapshot, ROA
    Figure 04: Global Immunoglobulins Market Snapshot, ROA
    Figure 05: Global Immunoglobulins Market Value (US$ Mn) Forecast, 2016?2026
    Figure 06: Global Immunoglobulins Market Value Share, by Applications (2017)
    Figure 07: Global Immunoglobulins Market Value Share, by Route of Administration (2017)
    Figure 08: Global Immunoglobulins Market Value Share, by End-user (2017)
    Figure 09: Global Immunoglobulins Market Value Share, by Region (2017)
    Figure 10: Global Immunoglobulins Market Value Share Analysis, by Applications, 2017 and 2026
    Figure 11: Global Immunoglobulins Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Neurology, 2016–2026
    Figure 12: Global Immunoglobulins Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hematology, 2016–2026
    Figure 13: Global Immunoglobulins Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2016-2026
    Figure 14: Global Immunoglobulins Market Attractiveness, by Applications, 2018–2026
    Figure 15: Global Immunoglobulins Market Value Share(%), by Route of Administration, 2017 and 2026
    Figure 16: Global Immunoglobulins Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Subcutaneous, 2016–2026
    Figure 17: Global Immunoglobulins Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Intramuscular, 2016–2026
    Figure 18: Global Immunoglobulins Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Intravenous, 2016–2026
    Figure 19: Global Immunoglobulins Market Attractiveness, by Route of Administration, 2018–2026
    Figure 20: Global Immunoglobulins Market Value Share(%), by End-user, 2017 and 2026
    Figure 22: Global Immunoglobulins Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Clinic, 2016–2026
    Figure 23: Global Immunoglobulins Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Homecare, 2016–2026
    Figure 21: Global Immunoglobulins Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospital, 2016–2026
    Figure 24: Global Immunoglobulins Market Attractiveness, by End-user, 2018–2026
    Figure 25: Global Immunoglobulins Market Value Share Analysis, by Region 2017 and 2026
    Figure 26: Global Immunoglobulins Market Attractiveness, by Region, 2018–2026
    Figure 27: North America Immunoglobulins Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
    Figure 28: North America Immunoglobulins Market Value Share (%), by Applications, 2017 and 2026
    Figure 29: North America Immunoglobulins Market Attractiveness, by Applications, 2018–2026
    Figure 30: North America Immunoglobulins Market Value Share (%), by Route of Administration, 2017 and 2026
    Figure 31: North America Immunoglobulins Market Attractiveness, by Route of Administration, 2018–2026
    Figure 32: North America Immunoglobulins Market Value Share (%), by End-user, 2017 and 2026
    Figure 33: North America Immunoglobulins Market Attractiveness, by End-user, 2018–2026
    Figure 34: North America Immunoglobulins Market Value Share (%), by Country, 2017 and 2026
    Figure 35: North America Immunoglobulins Market Attractiveness, by Country, 2018–2026
    Figure 36: Europe Immunoglobulins Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
    Figure 37: Europe Immunoglobulins Market Value Share (%), by Applications, 2017 and 2026
    Figure 38: Europe Immunoglobulins Market Attractiveness, by Applications, 2018–2026
    Figure 39: Europe Immunoglobulins Market Value Share (%), by Route of Administration, 2017 and 2026
    Figure 40: Europe Immunoglobulins Market Attractiveness, by Route of Administration, 2018–2026
    Figure 41: Europe Immunoglobulins Market Value Share (%), by End-user, 2017 and 2026
    Figure 42: Europe Immunoglobulins Market Attractiveness, by End-user, 2018–2026
    Figure 43: Europe Immunoglobulins Market Value Share (%), by Country/Sub-region, 2017 and 2026
    Figure 44: Europe Immunoglobulins Market Attractiveness, by Country/Sub-region, 2018–2026
    Figure 45: Latin America Immunoglobulins Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
    Figure 46: Asia Pacific Immunoglobulins Market Value Share (%), by Applications, 2017 and 2026
    Figure 47: Asia Pacific Immunoglobulins Market Attractiveness, by Applications, 2018–2026
    Figure 48: Asia Pacific Immunoglobulins Market Value Share (%), by Route of Administration, 2017 and 2026
    Figure 49: Asia Pacific Immunoglobulins Market Attractiveness, by Route of Administration, 2018–2026
    Figure 50: Asia Pacific Immunoglobulins Market Value Share (%), by End-user, 2017 and 2026
    Figure 51: Asia Pacific Immunoglobulins Market Attractiveness, by End-user, 2018–2026
    Figure 52: Asia Pacific Immunoglobulins Market Value Share (%), by Country/Sub-region, 2017 and 2026
    Figure 53: Asia Pacific Immunoglobulins Market Attractiveness, by Country/Sub-region, 2018–2026
    Figure 54: Latin America Immunoglobulins Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
    Figure 55: Latin America Immunoglobulins Market Value Share (%), by Applications, 2017 and 2026
    Figure 56: Latin America Immunoglobulins Market Attractiveness, by Applications, 2018–2026
    Figure 57: Latin America Immunoglobulins Market Value Share (%), by Route of Administration, 2017 and 2026
    Figure 58: Latin America Immunoglobulins Market Attractiveness, by Route of Administration, 2018–2026
    Figure 59: Latin America Immunoglobulins Market Value Share (%), by End-user, 2017 and 2026
    Figure 60: Latin America Immunoglobulins Market Attractiveness, by End-user, 2018–2026
    Figure 61: Latin America Immunoglobulins Market Value Share (%), by Country/Sub-region, 2017 and 2026
    Figure 62: Latin America Immunoglobulins Market Attractiveness, by Country/Sub-region, 2018–2026
    Figure 63: Middle East & Africa Immunoglobulins Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
    Figure 64: Middle East & Africa Immunoglobulins Market Value Share (%), by Applications, 2017 and 2026
    Figure 65: Middle East & Africa Immunoglobulins Market Attractiveness, by Applications, 2018–2026
    Figure 66: Middle East & Africa Immunoglobulins Market Value Share (%), by Route of Administration, 2017 and 2026
    Figure 67: Middle East & Africa Immunoglobulins Market Attractiveness, by Route of Administration, 2018–2026
    Figure 68: Middle East & Africa Immunoglobulins Market Value Share (%), by End-user, 2017 and 2026
    Figure 69: Middle East & Africa Immunoglobulins Market Attractiveness, by End-user, 2018–2026
    Figure 70: Middle East & Africa Immunoglobulins Market Value Share (%), by Country/Sub-region, 2017 and 2026
    Figure 71: Middle East  & Africa Immunoglobulins Market Attractiveness, by Country/Sub-region, 2018–2026
    Figure 72: Global Immunoglobulins Market Share Analysis, by Company (2017)
    Figure 73: Research & Development Expenses (2017)
    Figure 74: Breakdown of Net Sales (% Share), by Region (2017)
    Figure 75: Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017
    Figure 76: Breakdown of Net Sales (% Share), by Business Segment (2017)
    Figure 77: Research and Development Expenses, 2014–2018
    Figure 78: Breakdown of Net Sales (% Share), by Region (2017–2018)
    Figure 79: Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2018
    Figure 80: Research and Development Expenses, 2013-2017
    Figure 81: Breakdown of Net Sales (% Share), by Region (2017)
    Figure 82: Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017
    Figure 83: Breakdown of Net Sales (% Share), by Business Segment (2017)
    Figure 84: Research and Development Expenses, 2013-2017
    Figure 85: Breakdown of Net Sales (% Share), by Region (2017)
    Figure 86: Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017
    Figure 87: Breakdown of Net Sales (% Share), by Business Segment (2017)
    Figure 88: Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017
    Figure 89: Research and Development Expenses, 2013-2017
    Figure 90: Breakdown of Net Sales, by Business Segment, 2017
    Figure 91: Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2017
    Figure 92: Research & Development Cost, 2015–2017 (US$ Mn)
    Figure 93: Breakdown of Net Sales, by Business Segment, 2017
    Figure 94: Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2017
    Figure 95: Research & Development Cost, 2015–2017 (US$ Mn)
    Figure 96: Breakdown of Net Sales, by Business Segment, 2017
    Figure 97: Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2017
    Figure 98: Research & Development Cost, 2015–2017 (US$ Mn)
    Figure 99: Breakdown of Net Sales, by Business Segment, 2017
    Figure 100: Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2017
    Figure 101: Research & Development Cost, 2015–2017 (US$ Mn)
    Figure 102: Breakdown of Net Sales, by Business Segment, 2017
    Figure 103: Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2017
    Figure 104: Research & Development Cost, 2015–2017 (US$ Mn)

Copyright © Transparency Market Research, Inc. All Rights reserved